Benjamin Woodson

Papers

Total Citations

H-Index

About

Dr. Benjamin Woodson is a leading urologic researcher whose work focuses on renal pathophysiology, with a particular emphasis on improving the detection and mitigation of kidney injury. His most cited study, "Urinary Cystatin C and NGAL as Early Biomarkers for Assessment of Renal Ischemia-Reperfusion Injury," has garnered 23 citations and represents a significant contribution to nephrology. In this pivotal work, Dr. Woodson evaluated the utility of cystatin C and neutrophil gelatinase-associated lipocalin (NGAL) as early, non-invasive biomarkers for renal ischemic injury—potentially offering a more sensitive alternative to traditional serum creatinine. The study also explored the renoprotective potential of allopurinol, bridging biomarker discovery with therapeutic intervention. By investigating these markers in the context of partial nephrectomy, Dr. Woodson’s research directly addresses a critical clinical need: the early identification of acute kidney injury to improve patient outcomes. His work is notable for its translational impact, offering surgeons and nephrologists practical tools to assess renal damage in real time. Dr. Woodson’s contributions continue to shape the landscape of urologic and renal research, advancing both diagnostic precision and protective strategies in kidney surgery.